AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) presents a significant challenge in neurodegenerative research and clinical practice due to its complex etiology and progressive nature. The integration of artificial intelligence (AI) into the diagnosis, treatment, and prognostic modelling of AD holds promising potential to transform the landscape of dementia care. This review explores recent advancements in AI applications across various stages of AD management. In early diagnosis, AI-enhanced neuroimaging techniques, including MRI, PET, and CT scans, enable precise detection of AD biomarkers. Machine learning models analyze these images to identify patterns indicative of early cognitive decline. Additionally, AI algorithms are employed to detect genetic and proteomic biomarkers, facilitating early intervention. Cognitive and behavioral assessments have also benefited from AI, with tools that enhance the accuracy of neuropsychological tests and analyze speech and language patterns for early signs of dementia. Personalized treatment strategies have been revolutionized by AI-driven approaches. In drug discovery, virtual screening and drug repurposing, guided by predictive modelling, accelerate the identification of effective treatments. AI also aids in tailoring therapeutic interventions by predicting individual responses to treatments and monitoring patient progress, allowing for dynamic adjustment of care plans. Prognostic modelling, another critical area, utilizes AI to predict disease progression through longitudinal data analysis and risk prediction models. The integration of multi-modal data, combining clinical, genetic, and imaging information, enhances the accuracy of these predictions. Deep learning techniques are particularly effective in fusing diverse data types to uncover new insights into disease mechanisms and progression. Despite these advancements, challenges remain, including ethical considerations, data privacy, and the need for seamless integration of AI tools into clinical workflows. This review underscores the transformative potential of AI in AD management while highlighting areas for future research and development. By leveraging AI, the healthcare community can improve early diagnosis, personalize treatments, and predict disease outcomes more accurately, ultimately enhancing the quality of life for individuals with AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kumar, Y., Koul, A., Singla, R., & Ijaz, M. F. (2023) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-021-03612-z · Cited by 1,040
RetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
Alowais, S. A., Alghamdi, S. S., Alsuhebany, N., Alqahtani, T., Alshaya, A. I., Almohareb, S. N., Aldairem, A., Alrashed, M., Bin Saleh, K., Badreldin, H. A., et al. (2023) · BMC Medical Education · doi:10.1186/s12909-023-04698-z · Cited by 3,146
Deep learning for healthcare: review, opportunities and challenges
Miotto, R., Wang, F., Wang, S., Jiang, X., & Dudley, J. T. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbx044 · Cited by 3,076
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
The Amyloid-β Pathway in Alzheimer’s Disease
Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01249-0 · Cited by 1,952
Precision medicine, AI, and the future of personalized health care
Johnson, K. B., Wei, W., Weeraratne, D., Frisse, M. E., Misulis, K., Rhee, K., Zhao, J., & Snowdon, J. L. (2021) · Clinical and Translational Science · doi:10.1111/cts.12884 · Cited by 1,854
Artificial intelligence: A powerful paradigm for scientific research
Xu, Y., Liu, X., Cao, X., Huang, C., Liu, E., Qian, S., Liu, X., Wu, Y., Dong, F., Qiu, C.-W., et al. (2021) · The Innovation · doi:10.1016/j.xinn.2021.100179 · Cited by 1,726
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
The rise of artificial intelligence in healthcare applications
Bohr, A., & Memarzadeh, K. (2020) · Artificial Intelligence in Healthcare · doi:10.1016/b978-0-12-818438-7.00002-2 · Cited by 1,636
The Impact of Age on Cognition
Murman, D. (2015) · Seminars in Hearing · doi:10.1055/s-0035-1555115 · Cited by 1,619
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
Ahmed, Z., Mohamed, K., Zeeshan, S., & Dong, X. (2020) · Database · doi:10.1093/database/baaa010 · Cited by 1,035
Legal and Ethical Consideration in Artificial Intelligence in Healthcare: Who Takes Responsibility?
Naik, N., Hameed, B. M. Z., Shetty, D. K., Swain, D., Shah, M., Paul, R., Aggarwal, K., Ibrahim, S., Patil, V., Smriti, K., et al. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.862322 · Cited by 931
Brain Imaging in Alzheimer Disease
Johnson, K. A., Fox, N. C., Sperling, R. A., & Klunk, W. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006213 · Cited by 875
Multimodal deep learning models for early detection of Alzheimer’s disease stage
Venugopalan, J., Tong, L., Hassanzadeh, H. R., & Wang, M. D. (2021) · Scientific Reports · doi:10.1038/s41598-020-74399-w · Cited by 732
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 689
Applications of machine learning to diagnosis and treatment of neurodegenerative diseases
Myszczynska, M. A., Ojamies, P. N., Lacoste, A. M. B., Neil, D., Saffari, A., Mead, R., Hautbergue, G. M., Holbrook, J. D., & Ferraiuolo, L. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0377-8 · Cited by 595
Williamson, S. M., & Prybutok, V. (2024) · Applied Sciences · doi:10.3390/app14020675 · Cited by 567
Ethical Considerations of Using ChatGPT in Health Care
Wang, C., Liu, S., Yang, H., Guo, J., Wu, Y., & Liu, J. (2023) · Journal of Medical Internet Research · doi:10.2196/48009 · Cited by 541
The promise of machine learning in predicting treatment outcomes in psychiatry
Chekroud, A. M., Bondar, J., Delgadillo, J., Doherty, G., Wasil, A., Fokkema, M., Cohen, Z., Belgrave, D., DeRubeis, R., Iniesta, R., et al. (2021) · World Psychiatry · doi:10.1002/wps.20882 · Cited by 531
Enabling Technologies for Personalized and Precision Medicine
Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., et al. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.021 · Cited by 517
Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0084-2 · Cited by 476
Ethical Issues of Artificial Intelligence in Medicine and Healthcare
Farhud, D. D., & Zokaei, S. (2021) · Iranian Journal of Public Health · doi:10.18502/ijph.v50i11.7600 · Cited by 416
El-Sappagh, S., Alonso, J. M., Islam, S. M. R., Sultan, A. M., & Kwak, K. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82098-3 · Cited by 363
SHIFTing artificial intelligence to be responsible in healthcare: a systematic review
Siala, H., & Wang, Y. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.114782 · Cited by 358
The role of artificial intelligence in precision medicine
Mesko, B. (2017) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2017.1380516 · Cited by 343
AI-powered therapeutic target discovery
Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.010 · Cited by 341
Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
Rodriguez, S., Hug, C., Todorov, P., Moret, N., Boswell, S. A., Evans, K., Zhou, G., Johnson, N. T., Hyman, B. T., Sorger, P. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21330-0 · Cited by 299
van Oostveen, W. M., & de Lange, E. C. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042110 · Cited by 297
De Schepper, S., Ge, J. Z., Sierksma, A., Crowley, G., Ferreira, L. S. S., Garceau, D., Toomey, C. E., Sokolova, D., Rueda-Carrasco, J., Shin, S.-H., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01257-z · Cited by 295
Clinical applications of neuropsychological assessment.
Harvey, P. D. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.1/pharvey · Cited by 265
The Integration of Artificial Intelligence into Clinical Practice
Karalis, V. D. (2024) · Applied Biosciences · doi:10.3390/applbiosci3010002 · Cited by 255
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Chouliaras, L., & O’Brien, J. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02215-8 · Cited by 221
Artificial Intelligence for Clinical Prediction: Exploring Key Domains and Essential Functions
Khalifa, M., & Albadawy, M. (2024) · Computer Methods and Programs in Biomedicine Update · doi:10.1016/j.cmpbup.2024.100148 · Cited by 201
Explainable artificial intelligence in Alzheimer’s disease classification: a systematic review
Viswan, V., Shaffi, N., Mahmud, M., Subramanian, K., & Hajamohideen, F. (2024) · Cognitive Computation · doi:10.1007/s12559-023-10192-x · Cited by 195
Operationalising ethics in artificial intelligence for healthcare: a framework for AI developers
Solanki, P., Grundy, J., & Hussain, W. (2023) · AI and Ethics · doi:10.1007/s43681-022-00195-z · Cited by 157
Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
Winchester, L. M., Harshfield, E. L., Shi, L., Badhwar, A., Khleifat, A. A., Clarke, N., Dehsarvi, A., Lengyel, I., Lourida, I., Madan, C. R., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13390 · Cited by 130
A scoping review of artificial intelligence-based methods for diabetes risk prediction
Mohsen, F., Al-Absi, H. R. H., Yousri, N. A., El Hajj, N., & Shah, Z. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00933-5 · Cited by 125
Machine learning and digital biomarkers can detect early stages of neurodegenerative diseases
Chudzik, A., Śledzianowski, A., & Przybyszewski, A. W. (2024) · Sensors · doi:10.3390/s24051572 · Cited by 122
Rawas, S. (2024) · Discover Artificial Intelligence · doi:10.1007/s44163-024-00118-3 · Cited by 119
Popuri, K., Ma, D., Wang, L., & Beg, M. F. (2020) · Human Brain Mapping · doi:10.1002/hbm.25115 · Cited by 96
Blanco, K., Salcidua, S., Orellana, P., Sauma-Pérez, T., León, T., Steinmetz, L. C. L., Ibañez, A., Duran-Aniotz, C., & de la Cruz, R. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01304-8 · Cited by 73
Du, X., Novoa-Laurentiev, J., Plasek, J. M., Chuang, Y.-W., Wang, L., Marshall, G. A., Mueller, S. K., Chang, F., Datta, S., Paek, H., et al. (2024) · eBioMedicine · doi:10.1016/j.ebiom.2024.105401 · Cited by 69
Yilmaz, A., Ugur, Z., Bisgin, H., Akyol, S., Bahado-Singh, R., Wilson, G., Imam, K., Maddens, M. E., & Graham, S. F. (2020) · Metabolites · doi:10.3390/metabo10090357 · Cited by 65
Mirkin, S., & Albensi, B. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1094233 · Cited by 46
de la Fuente Garcia, S., Ritchie, C. W., & Luz, S. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200888 · Cited by 5
Cited by
Raza, M. L., Hassan, S. T., Jamil, S., Hyder, N., Batool, K., Walji, S., & Abbas, M. K. (2025) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2025.1557177 · Cited by 74
Metadata
- Authors
- Kale, M., Wankhede, N., Pawar, R., Ballal, S., Kumawat, R., Goswami, M., Khalid, M., Taksande, B., Upaganlawar, A., Umekar, M., Kopalli, S. R., & Koppula, S.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2024-11
- Volume
- 101
- Pages
- 102497
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W4402564832
- Cited by
- 183
- References
- 51
- FWCI
- 18.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.